Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Boards Blitz 2025: Dermatology Exam Preparation
Description
In this dermatology exam preparation session, presenter Avery discusses a series of cases using Codas to enhance understanding of various skin conditions. The session emphasizes the importance of recognizing morphological characteristics, disease associations, and potential treatments related to different dermatological diseases. Topics covered include subacute cutaneous lupus erythematosus, mycosis fungoides, metastatic breast cancer, cholesterol emboli, and various systemic conditions like systemic sclerosis and dermatomyositis. Specific attention is given to the importance of patient history, laboratory findings, and the clinical presentation of conditions like urticarial vasculitis and pityriasis rosea. The use of high-yield facts and recognition of key immunophenotypes in conditions such as mycosis fungoides and eosinophilic fasciitis is stressed. Avery encourages participants to integrate a comprehensive clinical picture during diagnosis and treatment, emphasizing the value of detailed examination and testing for optimal patient care. The session concludes with a reminder to always consider patient history and symptoms in the context of dermatologic findings.
View moreConclusions
- Increased comfort with morphology of different disease states leads to better clinical assessments in dermatology.
- The majority of patients with subacute cutaneous lupus erythematosus have anti-Ro positivity, with drug-induced cases common, especially in the elderly.
- Mycosis fungoides typically presents with specific immunophenotypes and distinct clinical stages, influencing diagnosis and treatment.
- Metastatic breast cancer often presents with specific histological features, such as single-file hyperchromatic cells, particularly affecting the chest wall.
- Cholesterol emboli often occur post-cath or post-anticoagulation, with eosinophilia being a common laboratory finding.
- Bexarotene is effective for tumor-stage mycosis fungoides but has side effects like central hypothyroidism and requires caution with certain medications.
- Orofacial granulomatosis is associated with systemic conditions like Crohn's disease or sarcoidosis, requiring thorough evaluations for systemic involvement.
- Salt-and-pepper dyspigmentation in systemic sclerosis signifies more severe disease and can lead to significant body image issues.
- Urticarial vasculitis may be associated with systemic lupus erythematosus and warrants investigation for underlying conditions.
- Genital exams are crucial for detecting concomitant genital lichen sclerosus in patients with extragenital conditions, highlighting gaps in clinical practice.
- Bolognia: 4th edition
- PMID: 27469583. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomized controlled, double-blind, parallel group trial. Lancet Respir Med. 2016.
- PMID: 28376288. Mycophenolate mofetil versus placebo for systemic sclerosis-related interstitial lung disease: An analysis of scleroderma lung studies I and II. Arthritis Rheumatol. 2017.
- PMID: 35138336. Treatment with mycophenolate mofetil for salt-and-pepper dyspigmentation caused by autoimmune sclerosing disease. JAMA Dermatol 2022.
- PMID: 22533994. Coexistence of lichen sclerosis and morphea: a retrospective analysis of 472 patients with localized scleroderma from a German tertiary referral center. JAAD 2012.
- PMID: 22004877. High frequency of genital lichen sclerosus in a prospective series of 76 patients with morphea: toward a better understanding of the spectrum of morphea. Arch Dermatol. 2012.
- PMID: 32091025. Morphea: a practical review of its diagnosis, classification and treatment. Gac Med Mex. 2019.
- PMID: 38748419. Clinical Course, Antifungal Susceptibility, and Genomic Sequencing of Trichophyton indotineae. JAMA Dermatol. 2024.
- PMID: 32188668. Schnitzler's Syndrome?